GHP Q3 2018

GHP / Q3 2018 3 Contents , 4. News 6. Truly Unique Dental Products 8. Uniquely Comprehensive Service 10. A Renowned Leader in TMJ Dysfunction Relief 12. Creating Strong Value in Biosimilars 14. Bringing the New Science of Enzyme Indicators to Market 16. Reaching for the Stars 18. Committed to Solving a Real Problem in the Healthcare Sector 20. Setting the Standard in Holistic Healthcare 21. Presenting the Expert in Alternative Healthcare 22. Reaching New Heights in Luxury Supported Living 26. Janssen Reports Positive Topline Results for ATLAS Phase III Study of a Novel, Long Acting Injectable Two-Drug Regimen for the treatment of HIV-1 28. ROX Medical Appoints Mike MacKinnon as Chief Executive Officer 30. Winners’ Listings